. Author manuscript; available in PMC: 2013 Mar 27.

Published in final edited form as: ACS Nano. 2012 Feb 16;6(3):2497–2505. doi: 10.1021/nn204885f

Table 1.

Effect of treatment on OSC-19-luc human head and neck squamous cell carcinoma cells’ radioresponse.

Treatment	Time required to grow to 40 mm³, d	Absolute growth delay, d	Normalized growth delay, d	Enhancement factor
Control	13.5 ± 0.3
PTX/PEG-HCCs	14.7 ± 0.8	1.2 ± 0.8
Cet/PTX/PEG-HCCs	16.0 ± 1.7	2.5 ± 1.7
RT	17.6 ± 1.1	4.1 ± 1.1
PTX/PEG-HCCs+RT	17.4 ± 0.7	3.9 ± 0.7	2.8 ± 0.7	0.68
Cet/PTX/PEG-HCCs+RT ^*	21.9 ± 1.0	8.4 ± 1.0	5.9 ± 1.0	1.44

NOTE: All data are means ± standard error.

1 of 8 mice whose tumor volume never reached 40 mm³ was not used in the analysis.